first large study of glp-1 receptor agonists during pregnancy Discontinuing GLP-1s before or early raises risk for complications GLP-1 Receptor Agonists in Pregnancy

Notably, whereas Gcg is robustly expressed in -cells, its expression is suppressed in -cells through binding of pancreatic and duodenal homeobox 1 (Pdx1), Pax4, and homeobox protein Nkx6.1 to the G1 element, thereby competitively preventing the binding of Pax6/Maf heterodimers to the G1 element (Figure 2) [100,139,140]

A reduction in neonatal growth was also seen when liraglutide was used during lactation without having been used during pregnancy ( Supplement 3 )

Patch pipettes, prepared with a micropipette puller (Narishige, Tokyo, Japan), had resistances of 45 M for whole-cell recordings and 68 M for cell-attached recordings

The observed heterogeneity across studies highlights the importance of individualized treatment strategies based on patient profiles and therapeutic goals

Issue: This quick reference guide presents the latest guidance and practical tips on the safe use of glucagon-like peptide-1 receptor agonists

S.AshleyE